Top segments and regional performance

Last year, the company generated ‪303.67 B‬ JPY, the most of which — ‪215.90 B‬ JPY — came from its top-performing segment, Pharmaceutical Wholesale, compared to ‪201.93 B‬ JPY the previous year. The greatest contribution came from Japan, which accounted for ‪303.67 B‬ JPY last year, with ‪289.53 B‬ JPY the year before.